Form 4 for CRVS Corvus Pharmaceuticals, Inc.

Accepted 2022-06-06 00:00:00 ET · period of report 2022-06-02 · accession 0001567619-22-012396 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2022-06-06	2022-06-02+	CRVS	MILLER RICHARD A MD	Pres, CEO, Dir	P - Purchase	$0.9842	+5,890	1.34M	+0.4%	+$5,797

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-06-02	P	A	4,830	$0.98	1,338,345	I By Trust	—	—	(F1) These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
2	Common	Common Stock	2022-06-06	P	A	890	$1.01	1,339,405	I By Trust	—	—	(F1) These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
3	Common	Common Stock	2022-06-02	P	A	170	$0.97	1,338,515	I By Trust	—	—	(F1) These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.